Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Jens J. Kort"'
Autor:
Meghan Elizabeth Sise, David Seth Goldberg, Douglas Earl Schaubel, Robert J. Fontana, Jens J. Kort, Rita R. Alloway, Christine M. Durand, Emily A. Blumberg, E. Steve Woodle, Kenneth E. Sherman, Robert S. Brown, Jr., John J. Friedewald, Niraj M. Desai, Samuel T. Sultan, Josh Levitsky, Meghan D. Lee, Ian A. Strohbehn, J. Richard Landis, Melissa Fernando, Jenna L. Gustafson, Raymond T. Chung, Peter Philip Reese
Publikováno v:
Kidney International Reports, Vol 7, Iss 2, Pp 241-250 (2022)
Introduction: Transplanting kidneys from hepatitis C virus (HCV) viremic donors into HCV-negative patients (HCV D-RNA-positive/R-negative) has evolved from experimental to “standard-of-care” at many centers. Nevertheless, most data derive from si
Externí odkaz:
https://doaj.org/article/b7e97dd8d0c64e328e842013af21b456
Autor:
Myung‐Ho Kim, Meghan E. Sise, Min Xu, David S. Goldberg, Robert J. Fontana, Jens J. Kort, Rita R. Alloway, Christine M. Durand, Robert S. Brown, Josh Levitsky, Jenna L. Gustafson, Peter P. Reese, Raymond T. Chung
Publikováno v:
Clinical Transplantation. 37
Publikováno v:
Journal of Clinical Oncology. 41:698-698
698 Background: Malnutrition/cachexia is common in PC and is associated with multiple adverse patient (pt) outcomes. Current NCCN guidelines recommend PERT in PC pts with exocrine pancreatic insufficiency (EPI). However, little evidence exists regard
Autor:
Diala E Harb, Vincent J. Picozzi, Raneem Hawari, Jens J Kort, Anas Najjar, Margaret T. Mandelson
Publikováno v:
Journal of Clinical Oncology. 39:400-400
400 Background: Current NCCN guidelines recommend PERT use in PC patients (pts) with symptoms of EPI. However, little evidence exists regarding clinical outcomes following PERT use in PC pts, especially those with nonresected disease. We present init
Autor:
Mamta K. Jain, Cristina Tural, Mark T. Nelson, Patrick Ingiliz, Sanjay Bhagani, Keikawus Arastéh, Jens J. Kort, Montserrat Laguno, Douglas Dieterich, Josep M. Guardiola, Richard Vinisko, Jerry O. Stern, Jürgen K. Rockstroh, Montserrat Manero, Vicente Soriano
Publikováno v:
AIDS (London, England). 29(5)
OBJECTIVE Faldaprevir is a potent, once-daily hepatitis C virus (HCV) NS3/4A protease inhibitor. STARTVerso4 assessed the efficacy and safety of faldaprevir and response-guided pegylated interferon α-2a/ribavirin (PegIFN/RBV) in individuals with HCV
Publikováno v:
Journal of Neuroimmunology. 173:23-34
The role of astrocytes in the pathogenesis of multiple sclerosis (MS) is not well understood. Astrocytes may modulate the activity of pathogenic T cells by presenting myelin antigens in combination with pro- or anti-inflammatory signals. Astrocytes h
Autor:
Wei Zhang, Eleanore Seibert, Birgit Girlich, Donald J. Tweedie, Manuel Haschke, Manuel Battegay, Curtis Cooper, Naitee Ting, Jens J. Kort, Charles H. Ballow, Tom S. Chan, John P. Sabo, Angela D. M. Kashuba, Drané O'Brien, Benjamin Lang, Yongmei Li
Publikováno v:
Journal of clinical pharmacology. 55(4)
The potential inhibition of the major human cytochrome P450 (CYP) enzymes by faldaprevir was evaluated both in vitro and in clinical studies (healthy volunteers and hepatitis C virus [HCV] genotype 1-infected patients). In vitro studies indicated tha
Autor:
Yongmei Li, Charles Ballow, Jens J. Kort, Benjamin Lang, Mabrouk Elgadi, Manuel Battegay, Manuel Haschke, Michael J. Schobelock, Ulrich Feifel, Rainard Fuhr, Birgit Girlich, John P. Sabo
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 59(10)
BACKGROUND Faldaprevir is a potent, once-daily hepatitis C virus (HCV) NS3/4A protease inhibitor. Studies were performed to investigate potential drug interactions between faldaprevir and the commonly used antiretrovirals darunavir/ritonavir, efavire
Autor:
Kelvin J.A. Davies, Maude Dull, Jens J. Kort, Dana R. Crawford, Kevin Leahy, Katharine W. Lawrence
Publikováno v:
Archives of Biochemistry and Biophysics. 368:67-74
We have recently reported a new oxidant- and calcium-inducible mRNA, adapt78, from hamster HA-1 cells. The adapt78 mRNA is induced in HA-1 cells under conditions where a protective adaptive response is observed and contains a translatable open readin
Autor:
Jens J. Kort
Publikováno v:
AIDS Research and Human Retroviruses. 14:1329-1339
Perturbation of astrocyte functions by HIV-1 infection may contribute to the pathogenesis of AIDS dementia complex (ADC). The present study investigated the possibility that astroglial transport of glutamate and aspartate, the major excitatory amino